Calypte Biomedical Corporation Completes First Sale of Aware(TM) HIV-1/2 OMT Rapid Oral Fluid Test in India
PORTLAND, Ore.--(BUSINESS WIRE)--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, today announced the first sale of its Aware™ HIV-1/2 OMT rapid oral fluid test in India. The tests were purchased by one of the paramilitary forces of the Government of India.